Meeting Abstracts of the 12th World Congress on the Menopause

References

• Lindsay R, Aitken J M, Anderson J B, Hart D M, MacDonald E B, Clarke A C. Long term prevention of postmenopausal osteoporosis by oestrogen: evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976; 1: 1038–1041
   PubMed Web of Science ®Google Scholar
• Lindsay R. The menopause: sex steroids and osteoporosis. Clin Obstet Gynecol 1987; 30: 847–859
   PubMed Web of Science ®Google Scholar
• Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density. Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1996; 276: 1389–1396
   PubMed Web of Science ®Google Scholar
• Lindsay R, Gallagher J C, Kleerekoper M, Pickar J H. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 2002; 287: 2668–2676
   PubMed Web of Science ®Google Scholar
• Bagger Y Z, Tanko L B, Alexandersen P, et al. Two to three years of hormone replacement treatment in healthy women have long term preventive effects on bone mass and osteoporotic fractures: the PERF study. Bone 2004; 34: 728–735
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Cauley J A, Robbins J, Chen Z, et al. for the Women's Health Initiative Investigators. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003; 290: 1729–1738
   PubMed Web of Science ®Google Scholar

References

• Archer D. F. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women. Menopause 2001; 8(4)245–251
   PubMed Web of Science ®Google Scholar
• Beral V., Bull D., Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005; 365(9470)1543–1551
   PubMed Web of Science ®Google Scholar
• Ettinger B., et al. Cyclic hormone replacement therapy using quarterly progestin. Obstet Gynecol 1994; 83(5 Pt 1)693–700
   PubMed Web of Science ®Google Scholar
• Beresford S. A., et al. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 1997; 349(9050)458–461
   PubMed Web of Science ®Google Scholar
• Doherty J. A., et al. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. Am J Obstet Gynecol 2007; 197(2)139–171
   PubMed Web of Science ®Google Scholar
• Bjarnason J. A., et al. Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group. Maturitas 1999; 32(3)161–170
   PubMed Web of Science ®Google Scholar
• Reed S. D., et al. Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer. Am J Obstet Gynecol 2004; 191(4)1146–1151
   PubMed Web of Science ®Google Scholar

References

• Davis S R, O'Neill S M, Eden J, et al. Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium—a pilot study. Menopause 2004; 11: 167–175
   PubMed Web of Science ®Google Scholar
• Stovall D W, Utian W H, Gass M LS, et al. The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety. Menopause 2007; 14: 510–517
   PubMed Web of Science ®Google Scholar

References

• Kenemans and Speroff, Maturitas 2005;51:21.
   Google Scholar
• Archer et al., J Clin Endocrinol Metab 2007;92:911.
   Google Scholar
• Hammer et al., Br J Obstet Gynaecol 2007;114:1522.
   Google Scholar
• Cummings et al., N Engl J Med, submitted (2008).
   Google Scholar
• Nijland et al., Maturitas 2007;58:164.
   Google Scholar
• Delmas et al., Osteoporos Int 2008 (in press).
   Google Scholar

• Joakimsen O. J Clin Epidemiol 2000; 53: 525–530
   PubMed Web of Science ®Google Scholar
• Dubey R K. Cardiovasc Res 2005; 66: 295–306
   PubMed Web of Science ®Google Scholar
• Parker W. Obstet Gynecol 2005; 106: 219–226
   PubMed Web of Science ®Google Scholar
• Lokkegaard E. Maturitas 2006; 53: 226–233
   PubMed Web of Science ®Google Scholar
• Atsma F. Menopause 2006; 13: 265–279
   PubMed Web of Science ®Google Scholar
• Lobo R A. Menopause 2007; 14: 562–566
   PubMed Web of Science ®Google Scholar

• Johnson T. Shattuck Lecture—Medicine and the media. New England Journal of Medicine 1998; 339(2)87–92
   PubMed Web of Science ®Google Scholar
• Nelkin D. An uneasy relationship: the tensions between medicine and the media. The Lancet 1996; 347: 1600–1603
   PubMed Web of Science ®Google Scholar
• Seigel D. Clinical trials, epidemiology, and public confidence. Statistics in Medicine 2003; 22: 3419–3425
   PubMed Web of Science ®Google Scholar
• Pickar J H. Do journals have a publication bias?. Maturitas 2007; 57: 16–19
   PubMed Web of Science ®Google Scholar
• DeMaria A N. Journal of the American College of Cardiology 2007; 50(3)286–287
   PubMed Web of Science ®Google Scholar
• Steinbrook R. Medical journals and medical reporting. New England Journal of Medicine 2000; 342(22)1668–1671
   PubMed Web of Science ®Google Scholar
• Callaham M C, Wears R L, Weber E. JAMA 2002; 287(21)2847–2850
   PubMed Web of Science ®Google Scholar
• Parker-Pope T. Menopause 2007; 14(6)1073
   Google Scholar

References

• Diczfalusy E. The population aging. Ginecol Reprod 1998; 6: 122–133
   Google Scholar
• Siseles N, Gutiérrez P, Sayegh F. The climacteric in Latin America: Actual state and future trends. In: The Menopause at the Millennium. The Proceedings of the 9th International Menopause Society World Congress on the Menopause. Yokohama, Japan. The Parthenon Publishing Group New York, London; 2000;108–116.
   Google Scholar
• Siseles N, Gutiérrez P. Do different cultures really explain different attitudes to the management of the menopause?. Medicographia 2001; 23(4)313–314
   Google Scholar
• Artiles Visbal L et al. Gender impact in the Climacterium, CIMEQ ‘99.Havanna, Cuba; 1999.
   Google Scholar
• Barnett EA. Perceptions of menopause: Importance of rol satisfaction in a peruvian town. Calfornia, Stanford Universty, 1986. In: Sennott-Miller Lee. Health and Socioeconomic situation of midlife and elderly women in Latin America and Caribe. In: Midlife and elderly women in Latin America and Caribe. PAHO/WHO, 1990:3–130.
   Google Scholar

References

• Royer, Catelo-Branco, Blummel, et al. The US National Cholesterol Education rogramme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. CLIMACTERIC 2007; 10: 164–170, Carr MC
   PubMed Web of Science ®Google Scholar
• Gomez, Carvajal, Benavides. Sindrome metabolico en la menopáusica. Rev Col Menop 2005; 11: 13–20
   Google Scholar
• Onatra, Garcia, Gamboa. Y col. Prevalencia del síndrome metabólico en mujeres posmenopáusicas en Bogota. Revista U.D.C.A. Universidad de Ciencias aplicadas y Ambientales 2006; 1: 43–53
   Google Scholar
• Consenso Colombiano de Síndrome metabolico. Rev Col Menop 2008. Aceptado para publicacion.
   Google Scholar

Bibliografía

• Wakatsuki A. Circulation 2001; 104: 1773–1778
   PubMed Web of Science ®Google Scholar
• PEPI Trial. JAMA 1995; 273: 199–203
   PubMed Web of Science ®Google Scholar
• Herkert O. Circulation 2001; 104: 2826–2831
   PubMed Web of Science ®Google Scholar
• Byrne C, et al. Cancer Causes Control 2001; 12: 103–110
   PubMed Web of Science ®Google Scholar
• JAMA 2002; 288: 325–333, (WHI E+P)
   Google Scholar
• JAMA 2004; 291: 1701–1712, (WHI E)
   PubMed Web of Science ®Google Scholar
• Abdalla H. Obstetrics and Gynecology, vol 66.
   Google Scholar

Reference

• Greenberg Quinlan Rosner Research Inc. Executive Summary – Healthy Sexuality Project. July 7, 2004. Washington, DC.
   Google Scholar

Reference

• Dennerstein et al. 2006. Hypoactive sexual desire disorder in menopausal women: A survey of western european women. J Sex Med 2006;3:212–222.
   Google Scholar

References

• Gupta J K, et al. Patient anxiety and experiences associated with an outpatient one-stop see and treat hysteroscopy clinic. Surgical endoscopy 2002; 18(7)1099–1104
   Web of Science ®Google Scholar
• Dey p, et al. Costs and benefits of a one-stop clinic compared with a dedicated breast clinic: a randomised controlled trial. BMJ 2002; 324: 507–510
   PubMed Web of Science ®Google Scholar
• Chan Y M, et al. Could precolposcopy information and counseling reduce women's anxiety and improve knowledge and compliance to follow-up?. Gynecologic Oncology 2004; 95(2)341–346
   PubMed Web of Science ®Google Scholar

Reference

• MS update recommendations on postmenopausal hormone therapy. Climateric 2007; 10: 181–194
   PubMed Web of Science ®Google Scholar